Brief: Stayble Therapeutics Q1 EBIT Loss Narrows To SEK 2.1 Million

Stayble Therapeutics AB

17/05/2021 07:06

May 17 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * Q1 EBIT LOSS SEK 2.1 MILLION VERSUS LOSS SEK 5.0 MILLION
YEAR
AGO
    * Q1 OPERATING COSTS SEK 2.1 MILLION VERSUS SEK 5.0 MILLION
YEAR
AGO
    * Q1 NET LOSS SEK 2.1 MILLION VERSUS LOSS SEK 5.4 MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr3ZZCv3 
Further company coverage:  STABL.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))